NCT04598646 2025-12-03
HIMALAYAS-P
University Health Network, Toronto
Phase NA Completed
Clinical Trials
35 trialsNCT03787966 2025-11-19
ATOPE
Universidad de Granada
Phase NA Completed
NCT06155331 2025-08-19
Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients
Tanta University
Phase 2 Completed
NCT04737265 2025-07-03
NTproBNP-Guide
Abramson Cancer Center at Penn Medicine
Phase 1/2 Completed
NCT05786014 2025-06-12
The Effects of Two Exercise Interventions on Breast Cancer Patients Undergoing Cardiotoxic Chemotherapies
University of Virginia
Phase NA Completed
NCT04568161 2025-04-03
Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses
University of Sao Paulo General Hospital
Phase NA Completed
NCT05403736 2025-02-06
CARMA
Cedars-Sinai Medical Center
Phase NA Completed
NCT04486573 2024-10-22
Cardiac Effects From Radiation Therapy by MRI
University of Colorado, Denver
Phase NA Completed
NCT03486340 2024-07-08
CATCH
Vejle Hospital
Phase NA Completed
NCT05676606 2024-03-08
Cardiotoxicity Monitoring With Single-lead Electrocardiogram
I.M. Sechenov First Moscow State Medical University
Phase NA Completed
NCT05923242 2024-01-11
ECHOS2
Washington University School of Medicine
Phase NA Completed
NCT02605512 2023-11-08
BACCARAT
Institut de Radioprotection et de Surete Nucleaire
Phase NA Completed
NCT02881203 2023-07-27
BRAVEHeart
University of Sydney
Phase NA Completed
NCT01719562 2023-05-19
MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum
Wake Forest University Health Sciences
Phase NA Completed
NCT03964142 2023-05-12
ONCORE
Hospital Clinico Universitario de Santiago
Phase NA Completed
NCT03389724 2022-11-08
Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia
Children's Cancer Hospital Egypt 57357
Phase 3 Completed
NCT00436566 2022-08-05
Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery
Mayo Clinic
Phase 2 Completed
NCT03166813 2022-06-08
Remote Ischaemic Preconditioning in Childhood Cancer
The University of Hong Kong
Phase NA Completed
NCT03940625 2022-05-25
ANKE
Heinrich-Heine University, Duesseldorf
Phase NA Completed
NCT01212926 2022-02-09
CA2D
University Hospital, Bordeaux
Phase NA Completed
NCT01009918 2021-03-30
Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab
University of South Florida
Phase 2 Completed
NCT04434404 2020-06-16
Evaluation of the Cardioprotective Effect of L-carnitine and Silymarin in Patients Receiving Anthracycline Chemotherapy
Horus University
Phase 4 Completed
NCT02006979 2019-10-25
Acute Exercise Cardioprotection From Doxorubicin
University of British Columbia
Phase 1 Completed
NCT02796365 2018-12-13
HF-PROACTIVE
Henry Ford Health System
Phase NA Completed
NCT01724450 2018-02-05
Ceccy
University of Sao Paulo
Phase 3 Completed
NCT00377559 2015-10-06
MYOTAX
Catharina Ziekenhuis Eindhoven
Phase 2 Completed
NCT00459771 2014-12-02
Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity
The Netherlands Cancer Institute
Phase 3 Completed
NCT00854568 2014-08-20
Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCL
Fudan University
Phase 3 Completed
NCT00003070 2014-08-05
Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer
Children's Oncology Group
Phase 3 Completed
NCT00003937 2014-08-05
Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma
Children's Oncology Group
Phase 3 Completed
NCT00005578 2014-07-24
Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease
Children's Oncology Group
Phase 3 Completed
NCT00002827 2013-08-26
Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease
Children's Oncology Group
Phase 3 Completed
NCT01095926 2013-06-28
Doxo
University Hospital Muenster
Phase 2 Completed
NCT01230983 2013-06-06
T-Cell #4
Children's Oncology Group
Phase 3 Completed
NCT00039481 2013-01-17
Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed